NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system, Organon Pharma Pty Ltd, CON-896
Product name
NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system
Sponsor name
Organon Pharma Pty Ltd
ARTG details
96229
Batches
U008243
Consent start
Consent no.
CON-896
Duration
The consent is effective for the aforementioned batches only from 16 December 2021 until 31 July 2022.
Standard
?Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 – Standard for labels of prescription and related medicines (TGO 91)
Non-compliance with standard
The packaging does not conform with the requirements of paragraph 8(1)(i) of
Therapeutic Goods Order No. 91 – Standard for labels of prescription and related
medicines (TGO 91) in that the labels do not include the current sponsor details
(Organon Pharma Pty Ltd).
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines